NCT04028531Recruiting
Understanding Chronic Lymphocytic Leukemia
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2750 (estimated)
- First submitted
- 26 Jun 2019
- Start date
- 29 Sept 1999
- Primary completion date
- 29 Sept 2030
- Lead sponsor
- Dana-Farber Cancer Institute
- Diseases
- Chronic lymphocytic leukaemia
- NCT number
- NCT04028531
What you commit to
- Study type: Observational
- Planned participants: 2750
- From 29 Sept 1999 to the primary completion date, 29 Sept 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
- Any low grade lymphoproliferative disorder
- Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dana-Farber Cancer Institute Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.